Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 64
  2. 65
  3. 66
  4. 67
  5. 68
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Theralizumab Biosimilar -­ Anti-­CD28 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1927-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
MDX-­1342 Biosimilar -­ Anti-­CD19 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1928-100

ProteoGenix 		100 ug Anmelden
Vergleichen
MDX-­1342 Biosimilar -­ Anti-­CD19 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1928-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
CC-­90002 Biosimilar -­ Anti-­Leukocyte surface antigen CD47 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1929-100

ProteoGenix 		100 ug Anmelden
Vergleichen
CC-­90002 Biosimilar -­ Anti-­Leukocyte surface antigen CD47 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1929-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
α/­γ Antibody (Kwar23) Biosimilar -­ Anti-­BIT mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1930-100

ProteoGenix 		100 ug Anmelden
Vergleichen
EC15 Antibody (5G12) Biosimilar -­ Anti-­CD33L3 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1931-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Abx-­Ma1 Biosimilar -­ Anti-­CD146 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1914-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
α/­γ Antibody (Kwar23) Biosimilar -­ Anti-­BIT mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1930-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
EC15 Antibody (5G12) Biosimilar -­ Anti-­CD33L3 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1931-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Atibuclimab Biosimilar -­ Anti-­CD14 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1811-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Atibuclimab Biosimilar -­ Anti-­CD14 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1811-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Bexmarilimab Biosimilar -­ Anti-­STAB1 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1817-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Bexmarilimab Biosimilar -­ Anti-­STAB1 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1817-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Cibisatamab Biosimilar -­ Anti-­CEACAM5&CD3E;CD3E mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1824-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Cibisatamab Biosimilar -­ Anti-­CEACAM5&CD3E;CD3E mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1824-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Anti-­CD80 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1843-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Galiximab Biosimilar -­ Anti-­CD80 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1843-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Nadunolimab Biosimilar -­ Anti-­IL1RAP mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1867-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Nadunolimab Biosimilar -­ Anti-­IL1RAP mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1867-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Anti-­hEGFR mAb -­ Research Grade Biosimilars Hu, Mu Mammalian cells PX-TA1019-Biotin

ProteoGenix 		100 ug-Bio Tin Anmelden
Vergleichen
Penpulimab Biosimilar -­ Anti-­Pd-­1 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1638-100UG

ProteoGenix 		100 ug Anmelden
Vergleichen
Penpulimab Biosimilar -­ Anti-­Pd-­1 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1638-1000UG

ProteoGenix 		1 mg Anmelden
Vergleichen
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal YTS191 Mu WB, FC, IHC Rat ICH1210-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal YTS191 Mu WB, FC, IHC Rat ICH1210-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Theralizumab Biosimilar -­ Anti-­CD28 mAb -­ Research Grade Anmelden Theralizumab Biosimilar - Anti-CD28 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
MDX-­1342 Biosimilar -­ Anti-­CD19 mAb -­ Research Grade Anmelden MDX-1342 Biosimilar - Anti-CD19 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
MDX-­1342 Biosimilar -­ Anti-­CD19 mAb -­ Research Grade Anmelden MDX-1342 Biosimilar - Anti-CD19 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
CC-­90002 Biosimilar -­ Anti-­Leukocyte surface antigen CD47 mAb -­ Research Grade Anmelden CC-90002 Biosimilar - Anti-Leukocyte surface antigen CD47 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
CC-­90002 Biosimilar -­ Anti-­Leukocyte surface antigen CD47 mAb -­ Research Grade Anmelden CC-90002 Biosimilar - Anti-Leukocyte surface antigen CD47 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
α/­γ Antibody (Kwar23) Biosimilar -­ Anti-­BIT mAb -­ Research Grade Anmelden α/γ Antibody (Kwar23) Biosimilar - Anti-BIT mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
EC15 Antibody (5G12) Biosimilar -­ Anti-­CD33L3 mAb -­ Research Grade Anmelden EC15 Antibody (5G12) Biosimilar - Anti-CD33L3 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Abx-­Ma1 Biosimilar -­ Anti-­CD146 mAb -­ Research Grade Anmelden Abx-Ma1 Biosimilar - Anti-CD146 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
α/­γ Antibody (Kwar23) Biosimilar -­ Anti-­BIT mAb -­ Research Grade Anmelden α/γ Antibody (Kwar23) Biosimilar - Anti-BIT mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
EC15 Antibody (5G12) Biosimilar -­ Anti-­CD33L3 mAb -­ Research Grade Anmelden EC15 Antibody (5G12) Biosimilar - Anti-CD33L3 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Atibuclimab Biosimilar -­ Anti-­CD14 mAb -­ Research Grade Anmelden Atibuclimab Biosimilar - Anti-CD14 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Atibuclimab Biosimilar -­ Anti-­CD14 mAb -­ Research Grade Anmelden Atibuclimab Biosimilar - Anti-CD14 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Bexmarilimab Biosimilar -­ Anti-­STAB1 mAb -­ Research Grade Anmelden Bexmarilimab Biosimilar - Anti-STAB1 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Bexmarilimab Biosimilar -­ Anti-­STAB1 mAb -­ Research Grade Anmelden Bexmarilimab Biosimilar - Anti-STAB1 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Cibisatamab Biosimilar -­ Anti-­CEACAM5&CD3E;CD3E mAb -­ Research Grade Anmelden Cibisatamab Biosimilar - Anti-CEACAM5&CD3E;CD3E mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Cibisatamab Biosimilar -­ Anti-­CEACAM5&CD3E;CD3E mAb -­ Research Grade Anmelden Cibisatamab Biosimilar - Anti-CEACAM5&CD3E;CD3E mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Galiximab Biosimilar -­ Anti-­CD80 mAb -­ Research Grade Anmelden Galiximab Biosimilar - Anti-CD80 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Galiximab Biosimilar -­ Anti-­CD80 mAb -­ Research Grade Anmelden Galiximab Biosimilar - Anti-CD80 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Nadunolimab Biosimilar -­ Anti-­IL1RAP mAb -­ Research Grade Anmelden Nadunolimab Biosimilar - Anti-IL1RAP mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Nadunolimab Biosimilar -­ Anti-­IL1RAP mAb -­ Research Grade Anmelden Nadunolimab Biosimilar - Anti-IL1RAP mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Cetuximab Biosimilar -­ Anti-­hEGFR mAb -­ Research Grade Anmelden Cetuximab Biosimilar - Anti-hEGFR mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu, Mu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug-Bio Tin
Lieferbar
Penpulimab Biosimilar -­ Anti-­Pd-­1 mAb -­ Research Grade Anmelden Penpulimab Biosimilar - Anti-Pd-1 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Penpulimab Biosimilar -­ Anti-­Pd-­1 mAb -­ Research Grade Anmelden Penpulimab Biosimilar - Anti-Pd-1 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD4 (YTS191) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone YTS191
Specific against Mu
Appl. WB, FC, IHC
Host Rat
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD4 (YTS191) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone YTS191
Specific against Mu
Appl. WB, FC, IHC
Host Rat
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 64
  2. 65
  3. 66
  4. 67
  5. 68
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top